Tevos Pharmaceuticals LLP
About Tevos Pharmaceuticals LLP
Data last updated:
Tevos Pharmaceuticals LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 February 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAR-9087.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Mrugank Jatin Shah and Haresh Sevantilal Shah.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at 108A Raghuvir Estate N.H. 8 At. Aslali, Ahmedabad, Gujarat, India – 382427.
As per the financials filed for FY 2022, the LLP reported a revenue of ₹12.03 Lakh. For the same year it recorded a net loss of ₹20.72 Lakh (net margin -172.2%) and EBITDA of ₹6.72 Lakh (EBITDA margin 55.8%).
The LLP is associated with 1 brand: Sweetmate.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address108A Raghuvir Estate N.H. 8 At. Aslali, Ahmedabad, Gujarat, India – 382427
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Tevos Pharmaceuticals LLP FY 2023 filings available
Tevos Pharmaceuticals LLP reported revenue of ₹12.03 Lakh for FY 2022.
Financial Statement Summary of Tevos Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | ₹12.03 Lakh | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | -₹20.72 Lakh | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Tevos Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | -172.2% | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Tevos Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Tevos Pharmaceuticals LLP
Tevos Pharmaceuticals has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mrugank Jatin Shah | Designated Partner | 13 Feb 2020 | 6 Years 7 Months | Current |
| Haresh Sevantilal Shah Also directs: Tevos Bioscience LLP, Farmadel Lifestyle Private Limited | Designated Partner | 13 Feb 2020 | 6 Years 7 Months | Current |
| Jatin Sevantilal Shah Also directs: Tevos Bioscience LLP | Designated Partner | 13 Feb 2020 | 6 Years 7 Months | Current |
Ownership and Shareholding of Tevos Pharmaceuticals LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tevos Pharmaceuticals LLP
Tevos Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Tevos Pharmaceuticals LLP
Tevos Pharmaceuticals operates one associated brand: Sweetmate. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers natural stevia-based sweeteners, jams, and drinks for health-conscious individuals. | sweetmate.in |
Employees and EPFO Compliance at Tevos Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Tevos Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tevos Pharmaceuticals LLP
Tevos Pharmaceuticals LLP has 3 designated partner changes on record since 2020: 3 appointments. The latest: Haresh Sevantilal Shah was appointed as Designated Partner on 13 Feb 2020.
Credit Ratings, Litigation & Regulatory Alerts for Tevos Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tevos Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tevos Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tevos Pharmaceuticals LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tevos Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tevos Pharmaceuticals LLP
Tevos Pharmaceuticals is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 13 February 2020 (6+ years old) and is registered under LLPIN AAR-9087.
Tevos Pharmaceuticals reported revenue of ₹12.03 Lakh for FY 2022.
Tevos Pharmaceuticals has 3 current designated partners:
- Mrugank Jatin Shah - Designated Partner
- Haresh Sevantilal Shah - Designated Partner
- Jatin Sevantilal Shah - Designated Partner
Tevos Pharmaceuticals reported a net loss of ₹20.72 Lakh (net margin -172.2%) and EBITDA of ₹6.72 Lakh (EBITDA margin 55.8%) for FY 2022, as per its filed financial statements.
The LLPIN (Limited Liability Partnership Identification Number) of Tevos Pharmaceuticals is AAR-9087. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Tevos Pharmaceuticals was incorporated on 13 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Haresh Sevantilal Shah was appointed as Designated Partner on 13 Feb 2020. Jatin Sevantilal Shah was appointed as Designated Partner on 13 Feb 2020. Mrugank Jatin Shah was appointed as Designated Partner on 13 Feb 2020.
The registered office of Tevos Pharmaceuticals is at 108A Raghuvir Estate N.H. 8 At. Aslali, Ahmedabad, Gujarat, India – 382427.
The total obligation of contribution is ₹1 Lakh.
Tevos Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.